Boxer Capital Management, LLC sold $4.3M of TNGX
other at Tango Therapeutics, Inc.. 633,000 shares at an average of $6.87, traded Oct 25, 2024, filed Oct 28, 2024.
Score components
- +8RoleOther
- +25Trade size$4.3M at market
- 0Share of holdings soldSold 8.6% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -31.1%, 3m -48.3%, 6m -74.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000895345-24-000485, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 25, 2024 | SOpen-market sale Common Stock | -633,000 | $6.87 | $4.3M | 6,690,642 | Oct 28, 2024 |
Related signals
Other insiders at Tango Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | Tango Therapeutics, Inc. | Adam Crystal President, R&D | $661k 27,000 shares | -19% | |
| 20Weak | Tango Therapeutics, Inc. | Jessica Newcomb Principal Accounting Officer | $199k 8,200 shares | -12% | |
| 9Weak | Tango Therapeutics, Inc. | Adam Crystal President, R&D | $604k 27,000 shares | -19% | |
| 37Weak | TNGXsell Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. owner | $4.0M 500,000 shares | -3% | |
| 37Weak | TNGXsell Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. owner | $2.6M 363,541 shares | -2% | |
| 37Weak | TNGXsell Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. owner | $5.1M 729,365 shares | -5% | |
| 37Weak | TNGXsell Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. owner | $2.1M 302,194 shares | -2% | |
| 37Weak | TNGXsell Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. owner | $7.7M 1,100,000 shares | -7% | |
| 30Weak | Tango Therapeutics, Inc. | Douglas Barry General Counsel | $16k 5,330 shares | -7% | |
| 42Moderate | Tango Therapeutics, Inc. | Daniella Beckman Chief Financial Officer | $25k 8,232 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.